Document is current
Any future updates will be listed below
-
Authors
Chaudhary, Shahid https://orcid.org/0000-0001-8996-6706
Ali, Zahir https://orcid.org/0000-0002-7814-8908
Tehseen, Muhammad
Haney, Evan F. https://orcid.org/0000-0003-3645-770X
Pantoja-Angles, Aarón https://orcid.org/0000-0002-5331-1414
Alshehri, Salwa https://orcid.org/0000-0003-1105-1930
Wang, Tiannyu
Clancy, Gerard J.
Ayach, Maya https://orcid.org/0000-0003-2213-9890
Hauser, Charlotte https://orcid.org/0000-0001-8251-7246
Hong, Pei-Ying https://orcid.org/0000-0002-4474-6600
Hamdan, Samir M. https://orcid.org/0000-0001-5192-1852
Hancock, Robert E. W. https://orcid.org/0000-0001-5989-8503
Mahfouz, Magdy https://orcid.org/0000-0002-0616-6365
- License Information
-
More Information
Article History
Received: 21 October 2022
Accepted: 27 February 2023
First Online: 16 March 2023
Competing interests
: MM, SC, and ZA have a pending patent application (63/484,445, “Recombinant production of antimicrobial peptides <i>in planta</i>”). EH and RH have filed for patent (WO2019145913A1) protection on the peptide sequences shown in this study. This patent has been assigned to their employer, the University of British Columbia, and has been licensed to ABT Innovations Inc., in which both have an ownership position. ABT Innovations Inc. is a subsidiary of ASEP Medical Holdings. EH is employed by ASEP and receives a salary, while RH holds an executive position and is on the Board of ASEP. The remaining authors declare no competing interests.
